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Here, we survey variation and dynamics of active
regulatory elements genome-wide using longitudinal
samples from human individuals. We applied Assay
of Transposase Accessible Chromatin with sequenc-
ing (ATAC-seq) to map chromatin accessibility in pri-
mary CD4+ T cells isolated from standard blood
draws from 12 healthy volunteers over time, from
cancer patients, and during T-cell activation. Over
4,000 predicted regulatory elements (7.2%) showed
reproducible variation in accessibility between indi-
viduals. Gender was the most significant attributable
source of variation. ATAC-seq revealed previously
undescribed elements that escape X chromosome
inactivation and predicted gender-specific gene
regulatory networks across autosomes, which coor-
dinately affect genes with immune function. Noisy
regulatory elements with personal variation in acces-
sibility are significantly enriched for autoimmune dis-
ease loci. Over one third of regulome variation lacked
genetic variation in cis, suggesting contributions
from environmental or epigenetic factors. These
results refine concepts of human individuality and
provide a foundational reference for comparing dis-
ease-associated regulomes.
INTRODUCTION
Understanding the basis of individual variation is a central goal in
genetics and epigenetics. The advent of global gene expression
and chromatin-mapping technologies has greatly increased our
understanding of gene regulatory mechanisms (Degner et al.,
2012; Kasowski et al., 2013; McVicker et al., 2013; Vernot
et al., 2012; Whitney et al., 2003). However, prior methods often
required tens of millions of cells. Investigators were forced to
expand cells through artificial means, such as immortalization
or extensive ex vivo expansion—manipulations that can signifi-
cantly alter the regulatory landscape. Hence, prior studies have
focused on the impact of inherited genetic variation on gene
expression or chromatin states (Degner et al., 2012; Kasowski
et al., 2013; McVicker et al., 2013; Vernot et al., 2012), but the fi-delity and variation of the human gene regulatory landscape
in vivo are surprisingly not known.
Assay of Transposase Accessible Chromatin with sequencing
(ATAC-seq) is a recently introduced and sensitive method to
map open chromatin sites, predicted transcription factor finding,
and nucleosome position from as few as 500 cells (Buenrostro
et al., 2013; Lara-Astiaso et al., 2014; Lavin et al., 2014), or
even in single cells (Buenrostro et al., 2015; Cusanovich et al.,
2015). Such a comprehensive molecular portrait of predicted
gene regulatory events affords a ‘‘personal regulome’’—a sum-
mary of gene regulatory events in a snapshot of time within a sin-
gle individual. Although ATAC-seq provides a possible approach
to investigate primary human cell types and minute clinical sam-
ples, the feasibility and accuracy of large-scale applications
have not been demonstrated. Here, we generate and analyze
58 high-resolution personal regulomes of a single cell type—
human CD4+ T cells—that comprised over 1.7 billion measure-
ments. We develop methods to integrate diverse sources of
genomic and epigenomic information to address the regulatory
variation as a function of individuality, time, and disease
(Figure 1A).RESULTS
Landscape and Variation of Personal Regulomes in
CD4+ T Cells
We assessed the landscape and variation of chromatin accessi-
bility in humanCD4+ T cells in 33 samples provided by 12 healthy
donors (Figure 1A). In this exploratory study, we wanted to docu-
ment dominant sources of regulome variation readily evident
from small numbers of healthy individuals; other well-selected
and larger populations are likely to reveal many other potential
contributions to regulome variation. Most donors gave at least
two independent samples, days to months apart; one donor
was sampled six times over 7 months (Table S1). From each
standard 5-ml blood draw, we enriched at least 50,000 CD4+
T cells by negative selection without ex vivo expansion (avoiding
potentially activating antibodies in positive selection) and per-
formed ATAC-seq to map the location and accessibility of regu-
latory elements genome-wide (Supplemental Experimental
Procedures). CD4+ T cells include multiple subsets (including
naive, memory Th1, Th2, Th17, Treg, and Tfh cells); known
frequency counts suggest that these major subsets would be
sampled by our approach (Maecker et al., 2012). Each libraryCell Systems 1, 51–61, July 29, 2015 ª2015 Elsevier Inc. 51
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Figure 1. Landscape of Individual Variation
in T-Cell Regulome
(A) Schematic outline of study design.
(B) Heatmap of regulatory elements with differ-
ential accessibility. Each column is a sample;
each row is an element. Samples and elements
are organized by two-dimensional hierarchical
clustering. Color scale indicates relative ATAC-
seq signal as indicated. Left: samples from the
same donor are labeled with the same color,
and sample ID is coded with gender, donor ID,
sample day, and replicate number; e.g.,
F9D38R1 indicates that this sample is female,
from donor 9 drawn at day 38 and is the first
replicate. Middle: three clusters of differential
accessible elements of interest. Right: correlation
of cluster activity with demographic variables,
and T-cell subtype signatures are shown in cor-
responding colors. The dotted line indicates
that p = 0.01, FDR < 0.05. Clusters i and iii are
associated with gender; cluster ii is associated
with a Th2 signature.
(C) Distribution of the variable regulatory element
associated with attributable demographic fea-
tures.
(D) Significance of the association of the variable
regulatory element accessibility with demographic
features.
(E) Distribution of genomic features of all and
differential accessible elements, respectively.
(F) Scale of variance of genomic features of all
elements with accessibility.was sequenced to obtain, on average, more than 30 million
paired-end reads. We used ZINBA (zero-inflated negative bino-
mial algorithm) (Rashid et al., 2011) to identify focal peaks of
chromatin accessibility that typify active regulatory elements,
and sequence counts within accessibility peaks were subjected
to quantile normalization to yield a quantitative portrait of active
regulatory elements in each sample. Pearson correlation of
replicates and irreproducibility discovery rate (IDR) analysis
(Landt et al., 2012) indicate high quality of the data and excellent
reproducibility between replicates (Figures S1A–S1D). System-
atic comparison of published ATAC-seq peaks to histone modi-
fication and DNase I hypersensitivity sequencing (DHS-seq)
confirmed that ATAC-seq highlights active enhancers and pro-
moters (Figures S1E and S1F).
To identify individual variation in T-cell regulomes, we applied
intrinsic analysis (Perou et al., 2000), a method that highlighted
elements that varied in accessibility across individuals but not
between repeat samples from the same individual (Figure 1B).
Noisy measurements that vary regardless of donor identity are
filtered out by this approach. We also used permutation analysis
as further protection against noisy data, using signals in
observed, but not permuted, data to estimate false discovery
rate (FDR) (Supplemental Experimental Procedures). The
selected elements reveal complex but distinctive patterns of
activity, so that replicate samples from the same donor at a
same time were always clustered together in unsupervised52 Cell Systems 1, 51–61, July 29, 2015 ª2015 Elsevier Inc.hierarchical clustering (12 of 12 pairs). Correlation of the pattern
of regulome activity with known subject variables revealed
potential relationships with gender, self-reported ancestry, and
other individual variation (p < 0.01, FDR < 0.05; Figures 1B and
1C). As CD4+ cells comprise several subsets, the individual
variation observed may reflect variations in cell subset com-
position in addition to gene-specific regulation. Comparison of
chromatin accessibility data (by DNase I hypersensitivity) from
purified T-cell subsets, including Th1, Th2, Th17, and Treg cells,
suggests that some of the regulome variation may be correlated
with cell subsets (Figure 1B, right).
CD4+ T cells from healthy donors exhibited 66,344 accessible
sites in our survey, inferred to be active regulatory elements
(Figure 1C). Approximately 92.8% of these sites showed
invariant activity across individuals and time, indicating a high
degree of fidelity in the regulatory landscape. Nearly 7.2% of
accessible sites (4,769 elements) show significant variable
activity (Z score > 1, FDR < 0.1, and fold change > 5). 24.7%
of these elements varied in accessibility in the same individual
over time and, hence, may reflect dynamic regulation of the
immune system (Figure 1C). The remainder elements showed
stable inter-individual differences, which can be associated
with known variables with different degrees of confidence
(Figure 1D). Notably, gender is the most informative variable, be-
ing strongly associated (p < 1010) with differential activity of
several hundred elements. In all cases, self-reported gender
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Figure 2. Regulatory Variation in Sex
Chromosomes
(A) Association of gender-specific regulatory
activity with sex chromosomes. Left: heatmap;
color scale indicates relative ATAC-seq signal as
indicated. Middle: bar graph indicates regulatory
elements on chromosomes X (chrX; dark red) and
Y (chrY; dark green). Right: for each regulatory
element, an FDR of significance estimated from
random permutation.
(B) Gene Ontology terms enriched in female (dark
red)- and male (dark green)-enriched regulatory
elements.
(C and D) Male versus female ATAC-seq signals
across (C) an autosome (chromosome 1) or
(D) X chromosome. Dotted lines indicate slopes
of 1 and 2, respectively. Regulatory elements of
X-inactivated and of known, predicted, or novel
escapees from XCI were color coded as described
in the figure. The x axis and y axis indicate the
average ATAC-seq reads per base.
(E) Statistical power of ATAC-seq (red) versus
microarray (blue) to detect known XCI escapee
genes is shown. ATAC-seq requires 11 samples of
each gender, while microarray requires 81 samples
of each gender to reach a power of 0.95 (dotted
line, p = 0.01).
(F) Distribution of genomic features in elements
that are X inactivated (left) or XCI escapees
(right).
(G) Averaged male- versus female-specific ATAC-
seq signals at FIRRE gene locus. The enhancer-
associated histone modification H3K27ac in
mixed-gender samples is shown for comparison.was concordant with biological sex as determined by chromo-
some complement (discussed later). In contrast, potentially reg-
ulatory impact from ancestry was less significant in this cohort,
and differential accessibility attributable to individual or dynamic
differences is weakly but broadly associated with thousands of
elements. Many elements currently assigned to the ‘‘individual’’
category are idiosyncratic in their differential activity; many are
‘‘private’’ variations that are observed reproducibly in one donor
but not across multiple individuals in our survey. Notably,
although some of the dynamic and individual variation correlated
with Th1 versus Th2 signals, gender—the most significant vari-
able—is not appreciably associated with known cell subsets
(Figure 1B). The variable elements are enriched for distal regula-
tory elements and depleted for promoters, suggesting variation
in long-range gene regulation (Figures 1E and 1F).
Gender-Specific Regulome in T Cells
Next, we focused on gender-specific variation in the T-cell reg-
ulome, because it emerged as the most significant attributable
source of inter-individual variation and because well-studied
mechanisms of dosage compensation provided a rich interpre-
tative framework for understanding our data. In mammals, malesCell Systems 1, 5have XY sex chromosomes, whereas
females have XX. Dosage compensation
occurs via random epigenetic silencing
of one of the two female X chromosomes,termed X chromosome inactivation (XCI), which is heritable
through somatic cell divisions over life (Flynn and Chang, 2014;
Lee and Bartolomei, 2013). XCI is controlled by several long
noncoding RNAs (lncRNAs), including XIST, which is transcribed
from and mediates the epigenetic silencing of the inactive
X chromosome (Xi). Thus, the active X chromosome (Xa) and Xi
harbor distinct chromatin modifications and gene expression
patterns. A subset of X-linked genes escape from XCI in a
tissue-specific fashion through poorly understood mechanisms,
leading to differential X-linked expression in male versus
female cells.
Among regulatory elements with significant differential activity
between male and female cells, a majority (but not all) mapped
to the sex chromosomes (Figures 2A and 2B). As expected,
only male samples showed signal for Y-chromosome-linked
elements, and female samples showed increased activity of
X-chromosome-linked elements. Gender-specific regulomes
may arise from effect of sex-specific hormones, random X inac-
tivation, X-linked escapee genes, or additional differences
(Rubtsova et al., 2015). Sex hormone changes may impact
all chromosomes, whereas the XCI effects are linked to the
X chromosome.1–61, July 29, 2015 ª2015 Elsevier Inc. 53
Comparative analysis of regulatory activity between males
and females across autosomes (e.g., chromosome 1) revealed
equivalent activity profiles at the chromosomal level, as evi-
denced by a slope of 1 in the two-dimensional plot (Figure 2C).
In contrast, a comparison of males and females across the
X chromosome readily revealed three types of elements: (1) ele-
ments that are dosage compensated and, therefore, have equiv-
alent activity between males and females (slope = 1, gray dots in
Figure 2D); (2) active elements on the Xi and, therefore, are only
active in female cells (slope = infinity; purple dots in Figure 2D;
e.g., XIST); and (3) elements that escape XCI and, therefore,
show a 2-fold increase in activity in female over male cells
(slope = 2; red, blue, and black dots in Figure 2D).
We identified 43 elements associated with 17 coding genes
(e.g., EIF1AX and KDM6A) and 3 noncoding genes known to
escape XCI, as well as elements associated with 7 escapees
predicted by others (Zhang et al., 2013) and 12 XCI escapees
that, to our knowledge, have not been reported previously (Fig-
ures 2D and S2; Table S2). We analyzed the ImmVar dataset,
which measured genome-wide mRNA levels of CD4+ T cells
from 163 healthy male and 244 female donors (Ye et al., 2014).
Gender-specific gene expression profiles validated 16 out of
17 known XCI genes and 6 of 7 novel XCI escapees predicted
by ATAC-seq that had well-measured transcripts (Figure S3A).
We note that escapee genes that were not validated tend to
have lower ATAC-seq signals and mRNA expression compared
to those that were validated (Figure 6), which may be below the
detection confidence of array technology.
Genes that escape XCI in females offered us an opportunity to
compare the accuracy and statistical power of ATAC-seq data
versus standard microarray data (Ye et al., 2014) (Figure 2E).
Such genes are anticipated to have a 2:1 dosage ratio in females
versus males. Whereas ATAC-seq analysis accurately identified
the 2-fold ratio in female versus males across a range of gene
activity levels (Figure 2D), microarrays underestimated the
difference (Figure S4). Using the known XCI escapees that are
detected by both ATAC-seq and RNA microarray analysis
(p value < 104, Student’s t test) as positive controls, we per-
formed a power analysis to determine the number of samples
required to have a 95% probability of detecting this true differ-
ence with a significance level <0.01. ATAC-seq requires only
11 samples of each gender, while mRNA microarray requires
81 samples of each gender to reach a power of 0.95 (Figure 2E),
indicating that ATAC-seq is over seven timesmore sensitive than
microarray. The ability of ATAC-seq to detect rare elements (e.g.,
Y-linked sequences inmales) and accurately quantify one versus
two copies of X-linked activity suggests that our methods are
sensitive and precise and could achieve excellent statistical
power with a small sample size.
The comparison of gender-specific regulomes also yielded
unexpected insights that are not possible from gene expression
measurements. For example, we observed that accessible ele-
ments that escape XCI are more likely to be found at promoters
and introns of known escapee genes but not at intergenic distal
regions (Figure 2F). Moreover, our analysis revealed evidence of
gender-specific regulatory landscapes of XCI escapees (Fig-
ure 2G). XCI escape has traditionally been considered simply a
failure of Xi silencing; hence, it was believed that the regulatory
pattern on the Xa will simply be duplicated on the Xi for escapee54 Cell Systems 1, 51–61, July 29, 2015 ª2015 Elsevier Inc.genes. Indeed, the term ‘‘XCI escape’’ implies this preconceived
notion; however, there is no direct evidence to support or refute
this model for XCI escape. We identified Xi-specific regulatory
elements on XCI escapees, which have signal only in female,
but not male, cells (Figure 2D, purple dots). For instance, FIRRE
is a recently described X-linked lncRNA that escapes XCI and is
involved in chromosome topological organization (Hacisuleyman
et al., 2014; Yang et al., 2015). RNA in situ hybridization docu-
mented two equivalent RNA foci in female cells and one focus
in male cells (Hacisuleyman et al., 2014). FIRRE contains a series
of putative intronic enhancers embedded throughout its locus,
as documented by the enhancer-associated modification his-
tone H3 lysine 27 acetylation (H3K27ac) in a survey of mixed-
sex cells (Bernstein et al., 2012). Intriguingly, our data suggest
that two FIRRE enhancers in intron 2 are active in male cells,
whereas over a dozen enhancers in introns 2–12 are active
only in female cells (Figure 2G). This regulatory divergence im-
plies gender-specific regulation, allele-specific regulation of
FIRRE on Xa versus Xi, or combinations of both strategies.
Extending the concept of allelic regulatory divergence, the se-
lection pressure for dosage compensation is thought to be the
maintenance of the expression level of homologous gene pairs
on the X and Y chromosomes (Bellott et al., 2014). Analysis of
the regulatory landscape of XY homolog pairs shows that all 15
pairs examined showed divergence on par with, or exceeding
that of, FIRRE alleles, indicating that the regulatory inputs into
the sex-linked gene homologs are distinctive as a rule (Figures
S5A–S5C). These results highlight the value of examining dosage
compensation from the perspective of the personal regulome.
Gender-Specific Regulome of Autosomes Reveal
Propensity for Autoimmunity
The dramatic chromatin accessibility differences between the
genders on sex chromosomes prompted us to examine the
scope of gender-specific differences on autosomes. Gender-
specific regulomes for T cells have special relevance to human
disease because of the strong epidemiological evidence indi-
cating an association between female sex and autoimmunity
(reviewed by Rubtsova et al., 2015). Four out of five patients
with any type of autoimmune disease are female; for some
common diseases, such as systemic lupus erythematosus, the
preponderance of females to males is nine to one. It has been
long postulated that epigenetic or regulatory differences be-
tween male and female immune cells may underlie autoimmune
susceptibility (Rubtsova et al., 2015), but gender-specific differ-
ences are incompletely understood.
We sought to identify gender-specific differences in gene reg-
ulatory networks from ATAC-seq data (Figure 3). DNA transposi-
tion occurs preferentially at nucleosome-free regions adjacent
to transcription factor (TF) binding sites, but the TF binding sites
themselves are protected from transposition. Hence, the pattern
of ATAC-seq reads can directly reveal the binding profiles of
hundreds of TFs whose cognate motifs are known at once
(Buenrostro et al., 2013). One caveat of this approach is that
TF family members that bind similar motifs cannot be distin-
guished. To this end, for each ATAC-seq profile, we identified
enriched TF motifs and factor footprints associated with ATAC-
seq peaks to generate a matrix of predicted TF-to-gene relation-
ships (Sherwood et al., 2014); the inferred regulation is weighted
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Figure 3. Gender-Specific T-Cell Regulome
across Autosomes
(A) Schematic of strategy to construct gender-
specific gene regulatory network. Three TFs—A, B,
and C—are depicted; B and C bind a target gene
differentially depending on gender. Purple arrows
depict expected ATAC-seq signal.
(B) Rank-ordered genes with predicted gender-
specific regulatory variation across their cognate
loci.
(C) Genomic tracks of FGL2 locus showing ATAC-
seq signal in male versus female samples. Top:
differential TF occupancy, defined as the TF
occupancy score in male samples minus female
samples, is shown. Upward signal indicates
greater occupancy in males; downward signal in-
dicates greater occupancy in females. The identity
of the TF with gender-specific signal is show-
n.Bottom: zoom-in view to visualize the ATAC-seq
footprint at an IRF motif.
(D) Rank-ordered TFs with gender-specific varia-
tion in occupancy profiles.
(E) Genomic track of NeST-IFNG locus; gender-
specific signal displayed as in (C).
(F) Functional enrichment of the top 1,000 genes
with gender-specific differences in ATAC-seq
signal. Black indicates Gene Ontology terms. Red
indicates disease terms.by the distance of the element to the transcription start site of
each gene (Figures S5D and S5E; Supplemental Experimental
Procedures). The end result is a set of active TF regulators and
their cognate sites on each gene for each individual. We then
compared male versus female samples for differences in this
predicted regulatory matrix (Figures 3A–3D; Figure S6F).
At the level of target genes, we found several hundred genes
that show significant differences in their predicted regulatory
network in male versus female T cells (Z score R 2; Figure 3B;
Table S3). The scale of variance—defined here as the pattern of
regulation in one gender that differs from the regulatory pattern
of the other gender (1  the square of Pearson correlation of
male versus female)—ranges from 0.13 to 0.61 for the top 100
genes; hence, such gender-specific variation is likely more
modulatory than deterministic. Ranking autosomal genes by
gender-specific regulatory variance revealed that the top diver-
gent genes include many genes with well-known and important
function in immune function or development, including FGL2,
GZMK, IFNG, CRTAM, CARD16, FYN, IL2, and IL6 (Figure 3B).
Indeed, significant gender-specific differences in T-cell produc-
tion of IFN-gamma and interleukin-2 (IL-2) have been docu-
mented in healthy children (Wiegering et al., 2009), validating
our unbiased approach. IFN-gamma is also known to be affected
by sex hormones (Rubtsova et al., 2015). In addition, direct mo-
lecular counting via Nanostring nCounter analysis of GZMK,
IL2, IL6, and NLRP2 transcripts indicates significant gender-
divergent responses to T-cell activation (Figure S3B), whichCell Systems 1, 5also supports our discovery (Ye et al.,
2014). In summary, among the top 500
predicted gender-specific genes, the
mRNA levels of 30 were measured usingNanostring, of which 20 showed significant differential expres-
sion between males versus females (p < 0.05, Student’s t test).
FGL2 stands out because it is the number one gene in the
entire genome for gender-specific variance in chromatin acces-
sibility and because the variance is nearly twice that of the next
most variable gene (Figure 3C). FGL2 shows greater promoter
ATAC-seq signal in male than in female T cells, and analysis of
specific TF signals revealed that interferon-regulatory factor
(IRF) family members and NHLH1 TFs are bound in male, but
not female, T cells (Figure 3C). Notably, FGL2 encodes a fibrin-
ogen-like protein secreted by regulatory T cells and other cells
that has immunosuppressive activity (Marsden et al., 2003).
Mouse knockout showed that Fgl2 is required for Treg function
and prevention of spontaneous autoimmunity (Shalev et al.,
2008). Similarly, CRTAM encodes a T-cell adhesion molecule
that has been recently recognized to critically control the differ-
entiation of CD4+ cells into inflammatory Th17 cells (Cortez
et al., 2014). Thus, gender-specific regulation of FGL2 and
CRTAM (which, to our knowledge, has not been reported) may
contribute, in part, to gender-linked differences for autoimmune
disease.
Extending this concept to the top 1,000 differentially regulated
genes, we note that these genes are significantly enriched for
biological functions in defense response, response to virus, im-
mune complex, and inflammatory disease (p < 106 for each,
FDR < 0.05, hypergeometric test; Figure 3F). The regulatory ele-
ments of many well-expressed genes, such as housekeeping1–61, July 29, 2015 ª2015 Elsevier Inc. 55
genes, are surveyed in these experiments but did not show
gender-specific differences. Thus, gender-specific regulation
in T cells is focused on genes with coherent biological function
that impact immune function and autoimmunity.
To understand the mechanisms of gender-specific regulome
divergence, we examined TF regulators that may exhibit
gender-specific activity. In contrast to the 1,000 target genes,
we observed just a handful of TFs with gender-associated diver-
gence (Figure 3D; Table S3). Among the most divergent is ESR2
(encoding estrogen receptor beta); its differential can be under-
stood based on the female hormone estrogen and serve as a
positive control. The top divergent regulator maps to the cognate
motif of ZBTB3, a little studied factor. ZBTB3 is poorly expressed
in CD4+ cells; hence, this motif may be recognized by another
zinc-finger family protein. Two notable gender-divergent regula-
tors are IRF family members, encoding well-studied TFs acti-
vated by interferon signaling and other signals in innate and
adaptive immunity responses that can cooperate or compete
with other TFs to exert regulatory effects (Ikushima et al.,
2013). Thus, a large number of genes were differently regulated,
but the differential regulation was associated with a small num-
ber of TF motifs that repeatedly showed differential activity
across many genes. This result suggests that a small number
of regulators may impact a large number of target genes to yield
the observed male-female divergence in the regulome.
The IFNG locus emerged as a prime example of intersection of
predicted regulatory divergence of both regulators and target
genes (Figures 3B and 3E). IFNG is the third most divergent
gene in our analysis. IFNG encodes interferon gamma and is a
key regulator of immune response and Th1 cell differentiation.
Multiple studies have documented gender-specific association
of allelic variants at IFNG regulatory elements or IFNG protein
levels with human disease. For example, IFNG variants are asso-
ciated with multiple sclerosis (Kantarci et al., 2008) and asthma
(Loisel et al., 2011) in males, but not females, but the mecha-
nisms are not known. NeST (also known as IFNG-AS1 or
TMEVPG1) is located proximal to IFNG and encodes an lncRNA
that is required to program active chromatin state and promote
expression of IFNG (Gomez et al., 2013). NeST is convergently
transcribed relative to IFNG, and a long isoform of NeST is tran-
scribed through the IFNG promoter. NeST itself is induced by
Th1 polarization (Hu et al., 2013), and murine NeST was first
discovered as a genetic locus that controlled pathogen resis-
tance and immune-mediated demyelinating disease (Bihl et al.,
1999).
We found that human IFNG and NeST show gender-specific
regulation (Figure 3E). A cluster of elements nearest to 50 of
IFNG is equally active in male versus female cells, but high-res-
olution analysis indicated that IRF family members occupied
these sites more strongly in males, but NF-YA and CST6 did
so in females. Males also have higher TF occupancy of NeST.
These results suggest that positive regulatory loops comprising
NeST, IRF, and IFNG may differ in a gender-specific fashion.
Consistent with this idea, careful genetic analyses showed that
NeST locus mutation has stronger pathogenic impact in male
than in female mice (Bihl et al., 1999). The fact that our unbiased
approach, examining target genes and regulators, indepen-
dently nominated IFNG highlights interferon signaling as a major
gender-specific regulatory feature in T cells. Our results support56 Cell Systems 1, 51–61, July 29, 2015 ª2015 Elsevier Inc.the considerable epidemiologic and genetic evidence of IFNG
involvement in gender variation of immune function and autoim-
munity and enrich this evidence by nominating specific TFs and
lncRNA as potential players in this mechanism.
T-Cell Chromatin Accessibility Variation Is Enriched
at Sites of Causal Genetic Variants for Autoimmune
Diseases
To understand how inherited DNA variation may underlie varia-
tions in personal regulomes, we intersected the set of variable
regulatory elements with a previously curated set of SNPs,
particularly SNPs linked to human diseases or variation in chro-
matin state or gene expression (Boyle et al., 2012; Farh et al.,
2014). Prior work indicated that most DNase I hypersensitive
site quantitative trait loci (dsQTLs) with strong effect size acted
in cis, meaning that they affected the chromatin feature where
the SNP itself is located (Degner et al., 2012). We identified the
genotypes using sequencing information in ATAC-seq peaks
and validated them by standard SNP genotyping of a subset of
donors (Figures 4A and 4B; Figures S6A and S6B). In addition,
we imputed unmeasured SNPs by applying a standard imputa-
tion method IMPUTE2 (Howie et al., 2009), using haplotypes
from the current version of 1000 Genomes as a reference. We
found that 48% and 18% of the 4,769 variably active elements
overlapped detected or imputed SNPs, respectively (Figure 4C).
Thus, more than a third (36%) of regulome variation occurs in
the absence of genetic variation in cis. Prior data further indicate
that only a small minority (<1%) of SNPs can significantly explain
variation in chromatin accessibility (Degner et al., 2012). Addi-
tional contributions of personal regulome variation may include
trans-acting genetic variants, environmental and epigenetic
factors, and variations in cell subset composition.
We discovered that the intersection of personal regulome vari-
ation and genetic variation is highly relevant for human disease.
We obtained SNP sets from the recently published set of causal
autoimmune SNPs (Farh et al., 2014); genome-wide association
studies (GWASs) and expression quantitative trait loci (eQTLs)
SNPs from NCBI, HapMap, and dbSNP138; disease SNPs (of
all organ systems) from RegulomeDB (Boyle et al., 2012); and
de novo SNPs from donors (Supplemental Experimental Proce-
dures). First, we asked whether ATAC-seq peaks of CD4+
T cells, representing active regulatory elements, are enriched
in SNPs as a class compared to the remainder of the genome.
Autoimmune casual SNPs are strongly enriched in CD4+ T-cell
ATAC-seq peaks (p < 1015, binomial test) (Figure S6C), consis-
tent with the idea that causal genetic variants in autoimmune dis-
eases impact immune cell enhancers (Farh et al., 2014). Second,
we tested whether ATAC-seq peaks that show inter-individual
variation are enriched for disease or eQTL SNPs compared to
invariant open chromatin sites in CD4+ T cells. We found that
autoimmune causal SNPs were most significantly enriched in
variable peaks compared to invariant open chromatin sites (Fig-
ure 4D), including causal variants for type 1 diabetes, rheumatoid
arthritis, lupus erythematosus, Crohn’s disease, and vitiligo
(Table S4). As negative controls, generic SNP sets from GWASs
of all diseases or eQTLs (which are not T cell specific) showed
no significant enrichment. Collectively, these results illustrate
the biological significance of the variable regulatory elements,
and variability in chromatin accessibility across individuals
A B
C D
Figure 4. Intersection of Regulome Varia-
tion with Genetic Variation
(A) Example of a reproducible regulome variation
without underlying sequence variation. Rep1 in-
dicates replicate 1, and Rep2 indicates replicate 2.
(B) Example of a reproducible regulome variation
with underlying sequence variation; genotype of
the two SNPs in each individual is indicated.
(C) Regulome variation intersection with detected
SNPs (dark blue) and imputed SNPs (light blue).
Over a third of variable peaks do not intersect with
SNPs (light purple).
(D) Enrichment of the indicated classes of SNPs
in variable ATAC-seq peaks versus invariant
peaks. Autoimmune causal SNPs showed highest
enrichment.emerges as a novel feature associated with locations of causal
disease SNPs. Variable elements are, by definition, ‘‘noisy’’
and capable of being readily switched on or off—properties
that may enable even a single-nucleotide mutation to change
its activity (Farh et al., 2014).
Regulome Dynamics in T-Cell Activation
Personal regulomes can also be interpreted with the help of
in vitro experiments that create an interpretative framework.
We measured changes in the chromatin accessibility caused
by specific hypothesis-driven perturbations in vitro and exam-
ined whether any of the same changes occurred in patient-
derived samples in vivo. We illustrate this concept by assessing
the regulome dynamics during T-cell activation. We isolated
CD4+ cells from donor 1 and stimulated them with PMA and
ionomycin; collected cells at 0, 1, 2, and 4 hr or 0 and 4 hr of
unstimulated controls in duplicate; and performed ATAC-seq
to map the regulatory elements genome-wide.
We identified 1,513 regulatory elements that gained or lost
accessibility upon T-cell activation from 1 to 4 hr (Figure 5).
770 elements, mapping to 591 genes, gained accessibility (pre-
sumably induced), while 773 elements, mapping to 593 genes,Cell Systems 1, 5lost accessibility (presumably repressed).
By comparing genome-wide mRNA mi-
croarray data in normal human CD4+
T cells (Ye et al., 2014), we found that,
on average, genes that gained ATAC-
seq signal showed significantly increased
mRNA levels upon activation (p = 5 3
1016), and, conversely, genes that lost
ATAC-seq signal also had decreased
mRNA expression (p = 3 3 104; Fig-
ure 5A). For gene loci that gain chromatin
accessibility, 61 showed increasedmRNA
level by more than 2-fold in mRNA ex-
pression, while only one gene showed
decreased mRNA level. Thus, chromatin
accessibility and gene expression are
highly concordant, as anticipated. This
finding further validates the accuracy of
ATAC-seq and our mapping of regulatory
elements to genes. As expected, regula-tory elements that gain accessibility during the T-cell activation
show significant Gene Ontology enrichment in regulation of
immune system processes, leukocyte activation, and immune
response (p < 1010; Figure 5b). T-cell activation strongly acti-
vates a suite of genes, including IL-2, in part through the inducible
TF NFAT (Northrop et al., 1994). ATAC-seq data visualized
enhancer activation at the IL2 locus and identified inducible
TF footprints of NFAT that is validated by published NFAT
ChIP-seq (Figures 5C–5E).
Next, we used the T-cell activation regulome to interpret
personal regulome variation. We discovered that a set of regu-
latory elements exhibiting inter-individual variation strongly
corresponded to elements that are coordinately deactivated
with T-cell activation; this very same cluster is also associated
with elevated Th2 gene signature (Figure 5F, cluster ii). Thus,
a previously unassigned set of personal regulome variation
may be related to the state of T-cell activation in these donors.
At a broader level, this new result illustrates the general concept
that we can use ATAC-seq profiles from laboratory-based, well-
defined perturbations or cell populations to interpret the com-
plex regulome patterns observed in clinical samples across
real populations.1–61, July 29, 2015 ª2015 Elsevier Inc. 57
A B
C
D
E
F
Figure 5. Regulome Dynamics during T-Cell Activation
(A) Left: heatmap showing time course of regulatory elements with differential ATAC-seq activity during T-cell activation. Each column is a sample; each row is an
element. Samples and elements are organized by supervised hierarchical clustering. Color scale indicates relative ATAC-seq signal as indicated. Samples from
untreated control and 4-hr control are indicated in green, and T-cell activation at 1, 2, and 4 hr are indicated in orange. Right: boxplots of mRNA expression levels
of the indicated genes in untreated control CD4+ T cells or after 4 hr activation with anti-CD3/CD28. Number of replicates = 15. p value was estimated from
Student’s t test.
(B) Gene Ontology terms of regulatory elements gain in accessibility during T-cell activation.
(C) Dynamics of ATAC-seq signal at IL2 locus (orange track) during T-cell activation (TCA) at the indicated times. NFAT ChIP-seq data in Jurkat cells (purple track)
is shown for comparison.
(legend continued on next page)
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Figure 6. Scale of Regulatory Variation as Function of Individuality
versus Disease
Regulome variation in CD4+ T cells derived from normal donors (green), during
T-cell activation (blue), or in T-cell leukemia (red) are ranked and compared.
There are 32, 517, and 1,800 regulatory elements in normal, T-cell leukemia,
and T-cell activation, respectively, whose variance is greater than 2.Regulome Variation in the Context of T-Cell Activation
and Cancer
Finally, we explored the scope of regulome variation across
individuals versus that with cell stimuli or a disease state.
Although comparison of regulomes in disease versus health
may be a powerful approach to understand disease mecha-
nism, an underlying assumption in cross-sectional studies
(i.e., comparing different individuals who are healthy versus
sick at the same point in time) is that the disease-relevant var-
iations significantly outnumber inter-individual variation—an
assumption that needs to be tested. To this end, we compared
ATAC-seq at four time points of human CD4+ T cells activated
with ionomycin and phorbol ester (n = 10 samples), as well as
leukemic CD4+ T cells isolated from patients in the leukemic
phase of CD4+ cutaneous T-cell lymphoma (CTCL; n = 15 sam-
ples). We found that the regulome dynamics in cancer and
T-cell activation are at least 10- to 100-fold greater than in-
ter-individual variation (Figure 6). Notably, for the largest ampli-
tude differences (>5-fold), the number of variable elements
in these different states starts to converge, highlighting the
importance of knowledge about inter-individual variation to
interpret disease-associated data. T-cell activation may exhibit
greater regulome variation in this analysis because the cell
population is temporally synchronized with respect to stimula-
tion, whereas the leukemia samples are not. These results
demonstrate the feasibility of using these data as a founda-
tional reference to which disease-associated regulomes can(D) Visualization of ATAC-seq footprint for TF NFAT (motif shown) in control cell
across all NFAT-binding sites in the genome were aligned on the motif and avera
(E) Boxplots of mRNA expression levels of IL2 in untreated control (green) and 4-h
and microarray (right). mRNA level from 355 or 15 healthy donors were measu
estimated from Student’s t test.
(F) Use of regulome signature of T-cell activation to interpret individual variation
personal variation from healthy donors (right) are shown. Cluster ii from Figure 1B
correlated with a Th2 signature. Donor sample dendrogram and demographic cobe compared. CTCL-specific regulome differences will be pre-
sented in detail elsewhere.
DISCUSSION
Here, we evaluate the feasibility of using a recently introduced
and sensitive genomic technology, ATAC-seq, to visualize the
personal regulome from a standard blood draw, the most com-
mon source of human samples for clinical diagnostics. This
work expands the number of primary human cell samples stud-
ied via ATAC-seq by 20-fold, and we provide foundational data
and methods to compare and visualize differences in personal
regulome. We were able to enumerate the number, location,
and potential sources of in vivo variation in chromatin accessi-
bility on a genome-wide scale, providing several notable and
unexpected findings. Our cohort was not designed to test
many possible potential contributors of regulome variation, and
lack of association here does not rule out their roles. Rather,
these data serve as a starting point to understand potential
sources of variation in chromatin accessibility in the population.
Our analyses suggest that sex is a major source of individual
variation in the T-cell regulome. We demonstrated the capacity
of ATAC-seq to detect even 2-fold differences in chromatin
access, and many predicted regulome differences were vali-
dated by independent gene expression measurements. We
identified X-linked chromatin accessibility sites that are more
active in female versus male T cells, which nominated elements
associated with escape from XCI in female cells. We further
identified autosomal sites that have differential accessibility
between sexes, which may relate to differences in sex hor-
mones, indirect regulation from sex-chromosome dosage,
or other sex-related associated differences (Rubtsova et al.,
2015). Variation between sexes has its root cause in genetics
from the differential inheritance of sex chromosomes, which, in
turn, leads to epigenetic differences in dosage compensation
and organismal differences, such as different hormonal environ-
ments and life history events. These events are often linked to
social or cultural roles that can also impact physiology. Our
work adds to the increasing recognition of sexual dimorphism
at the molecular level across many organs (Rinn et al., 2004).
Building on the large body of epidemiologic and clinical data
for gender differences in immune function and autoimmunity,
our results nominated specific genes, transcription factors, and
predicted regulatory circuits as potential drivers of gender differ-
ences for future studies. Similarly, we found that the majority
of the variations in the regulatory landscape may go beyond
genetic variation; such regulatory variation may arise from
epigenetic differences from life history or environmental factors,
such as the microbiome that offers many opportunities for future
investigations (Yurkovetskiy et al., 2013).s (green) versus cells after T-cell activation for 4 hr (orange). ATAC-seq signal
ged.
r T-cell activation with anti-CD3/CD28 (orange), obtained from Nanostring (left)
red by Nanostring or microarray, respectively. Log2 data are shown; p value
. Regulatory element accessibility during T-cell activation in vitro (left) versus
is found to exhibit coordinate deactivation during T-cell activation and is also
rrelation are as in Figure 1B.
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Finally, comparison of regulome variation in healthy donors
versus those with disease documented the feasibility of using
the personal regulome approach to investigate disease bio-
markers andmechanisms. The added value of regulome analysis
over mRNA biomarkers may arise from the fact that casual SNPs
associated with human diseases predominantly impact distal
enhancers (Farh et al., 2014) and, therefore, cannot be assessed
by traditional mRNA measurements alone. Recent discovery
of widespread allelic bias in enhancer-promoter interactions
motivates the need for regulome analysis in addition to RNA
measurements (Dixon et al., 2015), as exemplified by our detec-
tion of the differential regulatory landscape of FIRRE in males
versus females. Furthermore, regulome analysis may directly
investigate chromatin or TF pathways that are direct drug tar-
gets. While useful, potential limitations of ATAC-seq for personal
regulome prediction include Tn5 sequence bias, sensitivity as
a function of sequencing depth, and cell-type heterogeneity.
Integration of additional epigenomic measures, such as direct
TF binding or enhancer RNA synthesis, may improve enhancer
activity prediction (Dogan et al., 2015). As more than 1 billion
blood samples are obtained per year in the United States alone
(Becich, 2000), using ATAC-seq to monitor personal regulomes
in health and disease offers many exciting possibilities.
EXPERIMENTAL PROCEDURES
Enrichment of CD4+ cells from peripheral blood, ATAC-seq, and primary data
analysis were as described (Buenrostro et al., 2013). Differential peaks were
defined via intrinsic analysis, with a cutoff of Z score > 1, fold change > 5, and
an FDR< 0.1. The variance of each peakwas calculated using the ‘‘var’’ function
in R. Gene ontology enrichment scores were obtained from GREAT. Statistical
power analysis was performed using the ‘‘pwr.t2n.test’’ function in R. TF foot-
printing analysis was performed using PIQ v1.2 (Sherwood et al., 2014), with
input motifs set from JASPAR. Donor DNA was genotyped using Illumina Hu-
manOmni2.5-8+ v1.1 DNA Analysis BeedChip Kits. De novo mutation calling
was performed using VarScan v2.2.8, and unmeasured SNPs were imputed by
IMPUTE2. Enrichments of SNP sets were estimated by binomial test in R.
Complete methods are available in the Supplemental Information. Compu-
tational script used are available in Data Analysis Codes (Data S1).
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